Zelnorm (tegaserod), a new drug for irritable bowel syndrome
May 2002
Novartis will soon market Zelnorm (tegaserod), a new drug for irritable bowel syndrome.
It will be available first in Canada...later in the U.S.
Zelnorm will be used to treat CONSTIPATION-predominant IBS. It is approved for use only in women due to a lack of data for men.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive